Proteinase-inhibitor system state in patients with COPD

Olena B. Pavlenko (Dniepropetrovsk, Ukraine), Elena Pavlenko, Tetyana Pertseva

Source: International Congress 2015 – COPD: chronic disease and comorbidities
Session: COPD: chronic disease and comorbidities
Session type: Thematic Poster Session
Number: 694
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Olena B. Pavlenko (Dniepropetrovsk, Ukraine), Elena Pavlenko, Tetyana Pertseva. Proteinase-inhibitor system state in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 694

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014


Sputum biomarkers of inflammation in smokers and subjects with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015


Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Evaluation of arrhythmia frequency in patients with COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015


Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014

The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014


Differences in COPD: Smokers versus non smokers
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Prevalence of COPD in vascular diseases
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Efficacy of early COPD diagnosis and intervention system
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013


The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016



The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



COPD and BMI at primary level
Source: International Congress 2015 – Different data in COPD
Year: 2015

What should be part of a comprehensive assessment of COPD?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014